PDF(Sci-hub)
Abstract：
The use of extended criteria donors (ECD) in liver transplantation is increasing due to the organ shortage. Histological evaluation of the liver graft in the context of procurement is an important tool for extending the donor pool without affecting the quality of the transplanted organs. Macrovesicular steatosis is widely accepted as predictor of early allograft dysfunction (EAD), while other features, such as portal fibrosis, are poorly studied.
To identify morphological features, other than macrovesicular steatosis, that may affect recipients\' outcome.
Between 2014 and 2016, 132 donors with extended criteria underwent pre-transplant liver biopsy during procurement. Histological variables of the graft, donors\'/recipients\' clinical data, EAD and patient/graft survival were registered.
The recipients who received a graft with histological-proven portal fibrosis had a significant lower patient and graft survival in comparison to patients without fibrosis (P = 0.044 and P = 0.039, respectively). Donors\' dyslipidemia was significantly associated with the occurrence of EAD (P = 0.021). When dyslipidemia was combined with histological liver fibrosis a 54.5% incidence of EAD was observed (P = 0.012).
The histological assessment of liver fibrosis in pre-transplant biopsy of ECD grafts, together with donor\'s clinical data, provides important information on recipients\' outcome.
To identify morphological features, other than macrovesicular steatosis, that may affect recipients\' outcome.
Between 2014 and 2016, 132 donors with extended criteria underwent pre-transplant liver biopsy during procurement. Histological variables of the graft, donors\'/recipients\' clinical data, EAD and patient/graft survival were registered.
The recipients who received a graft with histological-proven portal fibrosis had a significant lower patient and graft survival in comparison to patients without fibrosis (P = 0.044 and P = 0.039, respectively). Donors\' dyslipidemia was significantly associated with the occurrence of EAD (P = 0.021). When dyslipidemia was combined with histological liver fibrosis a 54.5% incidence of EAD was observed (P = 0.012).
The histological assessment of liver fibrosis in pre-transplant biopsy of ECD grafts, together with donor\'s clinical data, provides important information on recipients\' outcome.
摘要：
暂无翻译
